Study identification

PURI

https://redirect.ema.europa.eu/resource/8020

EU PAS number

EUPAS8019

Study ID

8020

Official title and acronym

Characterising patients at risk of failed Diskus use in primary care

DARWIN EU® study

No

Study countries

Australia
France
Italy
Netherlands
Norway
Spain
Sweden
United Kingdom

Study description

The aim of this study is to identify patient characteristics in a large sample of primary care patients that use a Diskus inhaler. The prevalence and factors associated with inhaler misuse will be investigated. In addition we aim to assess the relationship between inhalation technique and clinical outcomes. These results should assist physicians in evaluating the potential impact of the type of device prescribed to a patient.This study will answer the following questions:• Which serious errors in Diskus inhaler technique are most frequently made?• Are certain patient characteristics linked to incorrect inhaler technique for Diskus?• Are patient reported outcomes linked to incorrect inhaler technique for Diskus?• Does incorrect inhaler technique correlate to asthma risk assessment?In addition, the type and frequency of serious errors being performed when using Diskus will be analysed to better characterise patient errors and identify ways in which inhaler technique may be improved.

Study status

Finalised
Research institution and networks

Institutions

Contact details

Emily Davis

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of interim report, if expected

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 
Other

More details on funding

Teva, RiRL
Study protocol
Initial protocol
English (1.67 MB - PDF)View document
Regulatory

Was the study required by a regulatory body?

No